Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Sof-Ldv'

Sof-Ldv published presentations and documents on DocSlides.

SMV + DCV + SOF Open label
SMV + DCV + SOF Open label
by summer
≥ 18 years. Chronic HCV infection. Genotype 1 or...
SOF/VEL 400/100 mg qd N = 75
SOF/VEL 400/100 mg qd N = 75
by danika-pritchard
W24. SOF/VEL. >. 18 years. Chronic HCV infect...
SMV 150 mg QD SOF 400 mg QD
SMV 150 mg QD SOF 400 mg QD
by alida-meadow
Randomisation. 1 : 1. 18-70 years. HCV genotype 1...
SOF/VEL/VOX
SOF/VEL/VOX
by pamella-moone
400/100/100 mg QD. N = 263. N = 152. W12. Placebo...
C-SWIFT Study: elbasvir/grazoprevir + SOF
C-SWIFT Study: elbasvir/grazoprevir + SOF
by myesha-ticknor
in genotypes 1 or 3, with or without cirrhosis. &...
SOF + RBV
SOF + RBV
by debby-jeon
SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....
C-SWIFT Study: elbasvir/grazoprevir + SOF
C-SWIFT Study: elbasvir/grazoprevir + SOF
by pamella-moone
in genotypes 1 or 3, with or without cirrhosis. &...
SOF/VEL + RBV
SOF/VEL + RBV
by celsa-spraggs
N = 69. >. 18 years. Failure to SOF/VEL . or ...
SOF/VEL/VOX
SOF/VEL/VOX
by celsa-spraggs
400/100/100 mg QD. N = 501. N = 440. W8. SOF/VEL ...
SOF/VEL
SOF/VEL
by trish-goza
400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...
SOF/VEL
SOF/VEL
by lois-ondreau
400/100 mg . qd. N = 500. N = 100. W12. Placebo. ...
SOF/VEL + GS-9857 N = 33
SOF/VEL + GS-9857 N = 33
by taylor291
>. 18 years. Genotype 2, 3, 4, 5 or 6. HCV RNA...
FISSION Design Objective
FISSION Design Objective
by travis
Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...
Safety and Efficacy of Daclatasvir
Safety and Efficacy of Daclatasvir
by tabitha
. Plus . Sofosbuvir. With or Without Ribavirin . ...
EASL 2019 HCV Conference Update
EASL 2019 HCV Conference Update
by sophia
April 10. –14. , 2019. Vienna, Austria. Disclaim...
MEF Modeling Activities Putting Models in Context
MEF Modeling Activities Putting Models in Context
by natalie
Outline. Challenges. MEF’s . Third Network Visio...
Treatment of Chronic HCV
Treatment of Chronic HCV
by lam
with Direct-Acting Antivirals (DAAs). www.hcvguide...
Slides for today’s webinar are available on the CIHS website at:
Slides for today’s webinar are available on the CIHS website at:
by tatiana-dople
Slides for today’s webinar are available on the...
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
by kittie-lecroy
Interim Analysis of a French Multicenter Compassi...
Success through Skype Operations Framework
Success through Skype Operations Framework
by calandra-battersby
Srini Raghavan . Ali Rohani. BRK2077. What does i...
Ledipasvir-Sofosbuvir ( Harvoni
Ledipasvir-Sofosbuvir ( Harvoni
by sherrill-nordquist
). Slide deck prepared . by: . David H. Spach, MD...
Simplified HCV Therapy in 2018
Simplified HCV Therapy in 2018
by phoebe-click
This program is s. upported. by educational gran...
Senior Leader Panel HQ Air Force Special Operations Command / FM
Senior Leader Panel HQ Air Force Special Operations Command / FM
by tatyana-admore
1. AFSOC Basics. Mission. : . Organize. , train ...
ARSOF WARFIGHTING CHALLENGES
ARSOF WARFIGHTING CHALLENGES
by min-jolicoeur
Enduring ARSOF First Order Problems, the Solution...
1 Briefing Graphics & Unit Symbols,
1 Briefing Graphics & Unit Symbols,
by phoebe-click
Wargaming Div, MCWL, Quantico. Updated 10 Jan 20...
ALLY-3 Design Objective SVR
ALLY-3 Design Objective SVR
by mitsue-stanley
12. (HCV RNA < 25 IU/ml), . with. 95% CI. DC...
ALLY-2
ALLY-2
by aaron
Design. Objective. SVR. 12. (HCV RNA < 25 IU/...
ALLY-2
ALLY-2
by tawny-fly
Design. Objective. SVR. 12. (HCV RNA < 25 IU/...
Sofosbuvir, Ribavirin, GS
Sofosbuvir, Ribavirin, GS
by min-jolicoeur
-. 0938 in GT 1-4. QUANTUM. Phase . 2b. Treatment...
COSMOS
COSMOS
by sherrill-nordquist
SOF + SMV + RBV. SOF + SMV. Randomisation. 2 : 1 ...
Daclatasvir in Combination With Sofosbuvir
Daclatasvir in Combination With Sofosbuvir
by mitsue-stanley
With Or Without Ribavirin Is Safe and Efficacious...
SMV 150 mg
SMV 150 mg
by faustina-dinatale
qd. + SOF 400 mg . qd. N = 40. W12. 18-70 years....
Hepatitis C Drug Pipeline
Hepatitis C Drug Pipeline
by cheryl-pisano
HCV WORLD CAB .  FEBRUARY 2014. BANGKOK, THAI...
Daclatasvir in Combination With Sofosbuvir
Daclatasvir in Combination With Sofosbuvir
by mitsue-stanley
With Or Without Ribavirin Is Safe and Efficacious...
Mr. John A. Wilcox
Mr. John A. Wilcox
by sherrill-nordquist
Director, J6/CIO . United States Special Operatio...
1 SOCOM
1 SOCOM
by pamella-moone
Acquisition Perspective . to. . NDIA. James W. C...
Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
by ahmir
ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2...
Virological characterization of patients with CHC and failure to a
Virological characterization of patients with CHC and failure to a
by isabella2
glecaprevir. /. pibrentasvir. or . voxilaprevir. ...
Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy
Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy
by della
Kristen M. Marks, MD. Assistant Professor. Weill C...
MEF Common Information Model Overview
MEF Common Information Model Overview
by adia
Jessie Jewitt. Modeling in the MEF. 4 Types of Mod...